| Literature DB >> 31481914 |
Abstract
Making the inevitability of mortality salient makes people more defensive about their self-esteem and worldviews. Theoretical arguments and empirical evidence point to a mediating role of arousal in this defensive process, but evidence from physiological measurement studies is scarce and inconclusive. The present study seeks to draw a comprehensive picture of how physiological arousal develops over time in the mortality salience (MS) paradigm, and whether contemplating one's mortality actually elicits more physiological arousal than reflecting on a death-unrelated aversive control topic. In a between-subjects design, participants were asked two open questions about their mortality or about dental pain. Cardiac, respiratory, and electrodermal indicators of arousal were measured both as participants provided written answers to the questions, and during a series of resting intervals surrounding the questions. A Bayes factor analysis indicated support for the hypothesis that the MS paradigm increases physiological arousal, both while answering the two open-ended questions and afterward. Regarding the MS versus dental pain comparison, the null hypothesis of no difference was supported for most analysis segments and signals. The results indicate that the arousal elicited by MS is not different from that elicited by dental pain salience. This speaks against the idea that worldview defense following MS occurs because MS produces higher physiological arousal. Of course, this finding does not rule the importance of other forms of arousal (i.e., subjective arousal) for MS effects.Entities:
Keywords: arousal misattribution; mortality salience; physiological arousal; threat and defense; worldview defense
Year: 2019 PMID: 31481914 PMCID: PMC6710453 DOI: 10.3389/fpsyg.2019.01893
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1A schematic illustration of the experimental protocol.
Mean differences, standard errors, and B values related to the comparison of each segment with baseline (upper half) and the mortality salience > dental pain salience comparisons (lower half).
| HR (bpm) | 3.57 | –1.18 | 2.77 | –0.93 | –0.33 | 0.45 | 0.30 | 0.63 | 0.89 |
| MAP (mmHg) | – | 0.27 | – | – | – | – | – | – | 0.41 |
| In HF-HRV (ms2) | –0.79 | 0.08 | –0.88 | 0.13 | –0.20 | –0.16 | –0.21 | –0.22 | –0.25 |
| In HF-HRV (ms2) | –0.20 | 0.18 | –0.26 | 0.25 | –0.05 | –0.03 | –0.09 | –0.04 | 0.09 |
| RR (cycles/min) | 3.68 | 0.78 | 3.70 | 0.18 | 1.07 | 1.50 | 1.34 | 0.95 | 0.01 |
| NSFR (n/min) | 5.84 | 0.39 | 6.33 | 0.48 | –1.18 | –0.95 | –0.72 | –0.27 | –1.07 |
| PEP (ms) | –3.10 | –0.68 | –3.43 | –0.71 | 1.54 | 0.01 | 1.39 | 1.36 | 0.02 |
| CO (l/min) | 0.37 | 0.89 | 0.69 | 0.03 | –0.22 | –0.09 | –0.10 | –0.07 | 0.13 |
| TPR (mmHg min/l) | –0.24 | 0.35 | –0.04 | 0.22 | 0.18 | 0.08 | 0.06 | 0.05 | –0.11 |
| HR (bpm) | –0.28 | –0.21 | –0.30 | –0.24 | –0.30 | –0.29 | –0.26 | –0.27 | –0.27 |
| MAP (mmHg) | – | 0.56 | – | – | – | – | – | – | 0.44 |
| In HF-HRV (ms2) | 0.12 | 0.07 | 0.14 | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 |
| In HF-HRV (ms2) | 0.13 | 0.08 | 0.13 | 0.09 | 0.08 | 0.09 | 0.10 | 0.09 | 0.09 |
| RR (cycles/min) | 0.77 | 0.58 | 0.63 | 0.57 | 0.65 | 0.46 | 0.51 | 0.57 | 0.54 |
| NSFR (n/min) | 0.82 | 0.58 | 1.39 | 1.00 | 0.85 | 0.85 | 0.91 | 1.00 | 0.80 |
| PEP (ms) | 2.27 | 2.26 | 2.48 | 1.78 | 1.86 | 2.62 | 2.10 | 2.18 | 1.74 |
| CO (l/min) | 0.47 | 1.20 | 0.57 | 0.41 | 0.53 | 0.47 | 0.46 | 0.43 | 0.51 |
| TPR (mmHg min/l) | 0.17 | 0.17 | 0.20 | 0.20 | 0.18 | 0.14 | 0.16 | 0.16 | 0.17 |
| HR (bpm) | >1000a | >1000a | >1000a | 106.23a | 0.26n | 0.46 | 0.28n | 1.98 | 24.15a |
| MAP (mmHg) | – | 0.17n | – | – | – | – | – | – | 0.22n |
| In HF-HRV (ms2) | >1000a | 0.31n | >1000a | 0.54 | 5.07a | 2.31 | 11.65a | 3.10a | 19.31a |
| In HF-HRV (ms2) | 0.45 | 1.52 | 1.04 | 6.01a | 0.18n | 0.16n | 0.21n | 0.16n | 0.23n |
| RR (cycles/min) | >1000a | 0.34 | >1000a | 0.16n | 0.52 | 17.89a | 3.58a | 0.54 | 0.15n |
| NSFR (n/min) | >1000a | 0.18n | >1000a | 0.17n | 0.36 | 0.27n | 0.20n | 0.15n | 0.35 |
| PEP (ms) | 0.36 | 0.15n | 0.37 | 0.16n | 0.20n | 0.15n | 0.18n | 0.18n | 0.15n |
| CO (l/min) | 0.20n | 0.19n | 0.30n | 0.15n | 0.16n | 0.15n | 0.15n | 0.15n | 0.15n |
| TPR (mmHg min/l) | 0.40 | 1.12 | 0.15n | 0.27n | 0.25n | 0.17n | 0.16n | 0.15n | 0.18n |
| HR (bpm) | –0.06 | 0.01 | –0.24 | –0.18 | –0.25 | –0.46 | –0.39 | –0.53 | –0.39 |
| MAP (mmHg) | – | 1.44 | – | – | – | – | – | – | 1.73 |
| In HF-HRV (ms2) | 0.24 | –0.07 | 0.05 | 0.05 | –0.02 | 0.15 | 0.02 | 0.09 | 0.19 |
| In HF-HRV (ms2) | –0.24 | –0.13 | –0.29 | –0.21 | –0.10 | –0.02 | 0.07 | 0.09 | 0.27 |
| RR (cycles/min) | –0.65 | 0.70 | –0.30 | 0.05 | 0.16 | 0.08 | 0.45 | –0.10 | 0.36 |
| NSFR (n/min) | –0.15 | –0.64 | –0.77 | –0.38 | 0.11 | –0.81 | –0.54 | –0.82 | –1.47 |
| PEP (ms) | –1.82 | 0.60 | –1.15 | –1.37 | –0.05 | –2.60 | –3.38 | –3.12 | –0.47 |
| CO (l/min) | 0.91 | 2.08 | 0.90 | 1.16 | 0.62 | 1.17 | 0.85 | 0.72 | 0.85 |
| TPR (mmHg min/l) | 0.05 | 0.04 | 0.24 | 0.12 | 0.71 | 0.01 | –0.16 | 0.04 | 0.42 |
| HR (bpm) | –0.53 | –0.43 | –0.57 | –0.54 | –0.56 | –0.54 | –0.53 | –0.57 | –0.51 |
| MAP (mmHg) | − | 1.03 | − | − | − | − | − | − | 0.85 |
| In HF-HRV (ms2) | 0.25 | 0.13 | 0.25 | 0.14 | 0.14 | 0.14 | 0.13 | 0.16 | 0.15 |
| In HF-HRV (ms2) | 0.24 | 0.16 | 0.22 | 0.17 | 0.17 | 0.17 | 0.19 | 0.18 | 0.17 |
| RR (cycles/min) | 0.74 | 0.83 | 0.69 | 1.06 | 1.51 | 0.75 | 1.05 | 0.94 | 0.94 |
| NSFR (n/min) | 2.11 | 1.20 | 1.51 | 1.29 | 1.18 | 1.29 | 1.57 | 1.66 | 1.49 |
| PEP (ms) | 3.87 | 3.80 | 3.32 | 3.45 | 3.42 | 4.74 | 3.25 | 3.90 | 3.29 |
| CO (l/min) | 0.86 | 2.27 | 0.91 | 0.98 | 1.08 | 0.90 | 0.74 | 0.78 | 0.75 |
| TPR (mmHg min/l) | 0.34 | 0.34 | 0.41 | 0.40 | 0.35 | 0.30 | 0.32 | 0.33 | 0.35 |
| HR (bpm) | 0.15n | 0.15n | 0.16n | 0.16n | 0.16n | 0.21n | 0.19n | 0.22n | 0.20n |
| MAP (mmHg) | – | 0.37 | – | – | – | – | – | – | 1.01 |
| In HF-HRV (ms2) | 0.23n | 0.17n | 0.15n | 0.16n | 0.15n | 0.26n | 0.15n | 0.17n | 0.34 |
| In HF-HRV (ms2) | 0.24n | 0.21n | 0.33n | 0.30n | 0.17n | 0.15n | 0.16n | 0.17n | 0.53 |
| RR (cycles/min) | 0.21n | 0.21n | 0.16n | 0.15n | 0.15n | 0.15n | 0.16n | 0.15n | 0.16n |
| NSFR (n/min) | 0.15n | 0.17n | 0.17n | 0.15n | 0.15n | 0.18n | 0.16n | 0.17n | 0.23n |
| PEP (ms) | 0.16n | 0.15n | 0.16n | 0.16n | 0.15n | 0.17n | 0.25n | 0.20n | 0.15n |
| CO (l/min) | 0.25n | 0.22n | 0.24n | 0.29n | 0.17n | 0.33n | 0.28n | 0.22n | 0.27n |
| TPR (mmHg-min/l) | 0.15n | 0.15n | 0.17n | 0.15n | 0.96 | 0.15n | 0.17n | 0.15n | 0.29n |
A list of the 30 most frequently used words occuring in participants written narratives, separately for the mortality salience and dental pain groups.
| angst | anxiety | 28 | angst | anxiety | 43 |
| ich | I | 27 | ich | I | 40 |
| tod | death | 24 | dass | that | 29 |
| leben | life | 23 | schmerzen | pain | 20 |
| körper | body | 22 | versuche | try | 17 |
| mehr | more | 16 | behandlung | treatment | 16 |
| passiert | happens | 16 | schnell | quickly | 11 |
| dass | that | 15 | schmerz | pain | 11 |
| seele | soul | 14 | vorbei | over | 10 |
| trauer | grief | 13 | zahnarzt | dentist | 8 |
| danach | after | 10 | hoffe | hope | 7 |
| freunde | friends | 10 | vermutlich | probably | 6 |
| mein | my | 9 | nervös | nervous | 6 |
| glaube | belief | 9 | unruhig | restless | 6 |
| familie | family | 7 | davor | prior to that | 6 |
| gedanken | thoughts | 7 | würde | would | 6 |
| vielleicht | maybe | 7 | gefühl | feeling | 6 |
| einfach | simply | 7 | einfach | simply | 6 |
| begraben | bury | 7 | bringen | bring | 6 |
| erde | ground | 7 | denke | think | 6 |
| kommt | comes | 6 | ruhig | calm | 6 |
| denke | think | 6 | abzulenken | distract | 6 |
| für | for | 6 | denken | think | 6 |
| nichts | nothing | 6 | gedanken | thoughts | 5 |
| bzw | respectively | 5 | bald | soon | 5 |
| weiß | know | 5 | unangenehm | unpleasant | 5 |
| ruhe | calm | 5 | mache | do | 4 |
| der | the | 5 | unbehagen | unease | 4 |
| art | kind | 5 | unwohlsein | discomfort | 4 |
| verbrannt | burnt | 5 | fühle | feel | 4 |
FIGURE 2Time courses of physiological parameters as a function of segment (BL, baseline; Q1, first question; R1, 1-min resting interval following first question; Q2, second question; R2, 6-min resting interval following second question) and experimental condition (solid line – dental pain salience, dotted line – mortality salience). Error bars indicate standard errors of the mean. Note the spikes in heart rate, HF-HRV, RR, and EDA that coincide with the question periods. These indicators also exhibit delayed physiological activation in the resting interval following Question 2. Impedance cardiographic indicators (PEP, CO, and TPR) exhibited no reactivity to the MS manipulation. The mortality salience and dental pain conditions did not differ on any of the physiological measures in any of the segments.